Trenzyme
Private Company
Total funding raised: $500K
Overview
Trenzyme is a privately held, revenue-generating German CRO specializing in customized cell culture and protein production services. With over two decades of operation, the company has established itself as a reliable partner for R&D outsourcing, leveraging scientific expertise and a modular, ISO9001-certified service model to accelerate client innovation. Its core value proposition lies in offering flexible, project-specific solutions from DNA to stable cell lines or purified proteins, saving clients time and resources.
Technology Platform
Modular service platform for customized cell line development (including iPSC differentiation) and recombinant protein production, utilizing a range of expression systems and ISO9001-certified processes.
Funding History
1Opportunities
Risk Factors
Competitive Landscape
Trenzyme competes in a fragmented global market of life science CROs, ranging from large, full-service organizations to small, niche providers. Its differentiation is based on high customization, scientific expertise in specific areas like iPSCs, and a client-centric communication model, rather than competing solely on scale or price.